Finzati - Logo
PTGX logo

Protagonist Therapeutics, Inc.

PTGXBiotechnology
$145.72
-3.08 (-2.07%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$9.40B
Growth
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 5.2%Positive free cash flow · 0.88Manageable debt level · 0.02Healthy liquidity · 12.71Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 12:35 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$145.72
Change-2.07%
Market Cap$9.40B
52W Range50.48 - 148.00
Beta1.79
Gross Margin97.34%
Oper. Margin-3.44%
Profit Margin-2.83%
Debt/Eq0.02
Current Ratio12.71
Quick Ratio12.71
Target$138.80

Investment DNA

How strong this company looks for long-term investors

41
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
46/100
Price Attractiveness
Cheap or expensive today
23/100
Why this score
Positive revenue growth · 5.2%Positive free cash flow · 0.88Manageable debt level · 0.02Healthy liquidity · 12.71Weak profitability

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$110.00
Mean
$138.80
Median
$145.00
High
$165.00

Company Overview

IPO: 8/11/2016
Industry: Biotechnology
P/B i: 9.03
Debt / Equity i: 0.02
Operating Margin: -343.63%
Net Margin: -282.83%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.02
Current Ratio: 12.71
Quick Ratio: 12.71
Status: Good

Insider Transactions

Recent executive and insider activity

Waddill William D.
Transaction: 06/23/2026
SELL
Change
-9,000
Price
$16.54
Filing
06/25/2026
Type
SELL
Waddill William D.
Transaction: 06/23/2026
SELL
Change
-9,000
Price
$117.94
Filing
06/25/2026
Type
SELL
Waddill William D.
Transaction: 06/10/2026
SELL
Change
-3,000
Price
$11.80
Filing
06/11/2026
Type
SELL